Detalhe da pesquisa
1.
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Diabetes Obes Metab
; 20(5): 1111-1120, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29266675